Acasti Pharma Inc. Class A - ADR Peer Comparison

$3.28

$-0.09 (-2.67%)

As on 21-Nov-2024 09:30EDT

Market cap

$34 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Edit

	Acasti Pharma Inc. Class A - ADR	Bausch Health Companies (BHC)	Cronos Group Inc. Common Share (CRON)	Arbutus Biopharma Corp (ABUS)	Sundial Growers - ADR
Market cap ($ Mln)	34	2,409	1,219	1,031	341
Revenue ($ Mln)	--	10,853	243	182	928
Net Profit ($ Mln)	-11.61	-1,098.00	69.79	153.05	-21.69
Net Margin (%)	--	-10.12	28.74	84.23	-2.34
RoE (%)	-19.69	--	5.60	91.29	-2.00
Price to Earnings	--	--	17.42	6.06	--
Price-To-Book	0.59	18.78	1.14	3.64	0.44

Cashflow
Ratios

Cashflow ($ Mln)

	Acasti Pharma Inc. Class A - ADR	Bausch Health Companies (BHC)	Cronos Group Inc. Common Share (CRON)	Arbutus Biopharma Corp (ABUS)	Sundial Growers - ADR
Cash From Operating Activities	-12.33	1,597.00	18.84	-64.85	54.91
Cash Flow from Investing Activities	--	-454.00	175.15	22.95	17.76
Cash from Financing Activities	7.36	-868.00	-1.23	52.00	-49.36
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Acasti Pharma Inc. Class A - ADR	Bausch Health Companies (BHC)	Cronos Group Inc. Common Share (CRON)	Arbutus Biopharma Corp (ABUS)	Sundial Growers - ADR
ROCE (%)	-19.75	-0.22	3.79	-64.08	-7.11
ROE (%)	-19.69	4.00	3.80	-68.76	-8.08
ROA (%)	-15.72	-0.17	3.56	-50.65	-6.72
EBIT Margin (%)	--	--	--	--	--
Net Margin (%)	--	-0.48	34.93	-1,133.04	-10.30
Cash Profit Margin (%)	--	--	--	--	--

Growth Ratios

	Acasti Pharma Inc. Class A - ADR	Bausch Health Companies (BHC)	Cronos Group Inc. Common Share (CRON)	Arbutus Biopharma Corp (ABUS)	Sundial Growers - ADR
Revenue Growth (%)	--	0.10	0.35	-0.66	0.01
EBIT Growth (%)	-152.17	--	--	--	--
Net Profit Growth (%)	71.50	92.23	155.54	4.02	45.10
EPS Growth (%)	--	0.92	1.55	0.15	0.45
Book Value Growth (%)	--	--	--	--	--

Valuation Ratios

	Acasti Pharma Inc. Class A - ADR	Bausch Health Companies (BHC)	Cronos Group Inc. Common Share (CRON)	Arbutus Biopharma Corp (ABUS)	Sundial Growers - ADR
Price / Earnings	--	-65.18	19.01	-8.88	-4.97
Price / Book Value	--	-2.34	0.73	6.38	0.42
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	2.04	7.54	1.51	-7.38	-9.08
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Acasti Pharma Inc. Class A - ADR	Bausch Health Companies (BHC)	Cronos Group Inc. Common Share (CRON)	Arbutus Biopharma Corp (ABUS)	Sundial Growers - ADR
Debt to Equity	0.00	-17.06	0.00	0.06	0.13
Short term debt to equity ratio	0.00	-2.14	0.00	0.00	0.03
Current Ratio	6.01	0.86	18.84	8.15	5.10
Quick Ratio	6.01	0.62	18.17	5.95	3.67
Interest Coverage	-16.85	1.35	--	-509.36	-12.72

Operating Efficiency Ratios

	Acasti Pharma Inc. Class A - ADR	Bausch Health Companies (BHC)	Cronos Group Inc. Common Share (CRON)	Arbutus Biopharma Corp (ABUS)	Sundial Growers - ADR
Debtors to sales (%)	--	22.23	25.31	39.04	3.05
Asset Turnover	0.00	0.36	0.10	0.04	0.65
Receivable days	--	78.51	101.93	123.85	10.95
Inventory Days	--	206.06	125.77	-470.06	69.44
Payable days	37,338.51	90.26	57.51	733.01	13.18
Cash Conversion Cycle	--	194.31	170.19	-1,079.22	67.20

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly